BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qu F, Zhu B, Hu YL, Mao QS, Feng Y. LncRNA HOXA-AS3 promotes gastric cancer progression by regulating miR-29a-3p/LTβR and activating NF-κB signaling.Cancer Cell Int. 2021;21:118. [PMID: 33602223 DOI: 10.1186/s12935-021-01827-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu B, Chen JJ, Feng Y, Yang JL, Huang H, Chung WY, Hu YL, Xue WJ. DNMT1-induced miR-378a-3p silencing promotes angiogenesis via the NF-κB signaling pathway by targeting TRAF1 in hepatocellular carcinoma. J Exp Clin Cancer Res 2021;40:352. [PMID: 34749775 DOI: 10.1186/s13046-021-02110-6] [Reference Citation Analysis]
2 Zhang HY, He CC, Zhong DF. Long non-coding RNA CCDC183-AS1 regulates gastric cancer AGS cell proliferation, migration, and invasion by targeting miR-1301-3p. Shijie Huaren Xiaohua Zazhi 2021; 29(17): 990-998 [DOI: 10.11569/wcjd.v29.i17.990] [Reference Citation Analysis]
3 Liu B, Xiang W, Liu J, Tang J, Wang J, Liu B, Long Z, Wang L, Yin G, Liu J. The regulatory role of antisense lncRNAs in cancer. Cancer Cell Int 2021;21:459. [PMID: 34461912 DOI: 10.1186/s12935-021-02168-4] [Reference Citation Analysis]
4 Cen X, Huang Y, Lu Z, Shao W, Zhuo C, Bao C, Feng S, Wei C, Tang X, Cen L, Guo W, Tian X, Tang Q, Huang X. LncRNA IGFL2-AS1 Promotes the Proliferation, Migration, and Invasion of Colon Cancer Cells and is Associated with Patient Prognosis. Cancer Manag Res 2021;13:5957-68. [PMID: 34377016 DOI: 10.2147/CMAR.S313775] [Reference Citation Analysis]
5 Siniscalchi C, Di Palo A, Russo A, Potenza N. Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation. Front Genet 2021;12:678994. [PMID: 34163530 DOI: 10.3389/fgene.2021.678994] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Liu Z, Hu K, Wang X, Zhang Y, Wang W, Wu Y. lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells. Open Medicine 2022;17:266-79. [DOI: 10.1515/med-2021-0406] [Reference Citation Analysis]
7 Jiang P, Ma X, Han S, Ma L, Ai J, Wu L, Zhang Y, Xiao H, Tian M, Tao WA, Zhang S, Chai R. Characterization of the microRNA transcriptomes and proteomics of cochlear tissue-derived small extracellular vesicles from mice of different ages after birth. Cell Mol Life Sci 2022;79:154. [PMID: 35218422 DOI: 10.1007/s00018-022-04164-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yang YL, Chang YH, Li CJ, Huang YH, Tsai MC, Chu PY, Lin HY. New Insights into the Role of miR-29a in Hepatocellular Carcinoma: Implications in Mechanisms and Theragnostics. J Pers Med 2021;11:219. [PMID: 33803804 DOI: 10.3390/jpm11030219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Raei N, Safaralizadeh R, Hesseinpourfeizi M, Yazdanbod A, Pourfarzi F, Latifi-Navid S. Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance. Life Sci 2021;284:119933. [PMID: 34508759 DOI: 10.1016/j.lfs.2021.119933] [Reference Citation Analysis]